Meta-analysis demonstrated that animals receiving HDAC6 inhibitors developed significantly smaller cerebral infarctions than controls (standardised mean difference −1.25, 95% confidence intervals: −1.68, −0.81). The gene discussed is HDAC6; the disease is brain infarction.